In lymphoma cells, exposure to lenalidomide leads to cereblon-mediated degradation of transcription factors Ikaros (IKZF1), Aiolos (IKZF3) and interferon response 4 (IRF4) and subsequent inhibition of nuclear factor kappa B [175]. The gene discussed is IKZF3; the disease is lymphoma.